Evidence map›Paper›PMID 28872669›Full record

ReviewBritish journal of pharmacology2018

GPCR signalling from within the cell.

Yuh-Jiin I Jong, Steven K Harmon, Karen L O'Malley

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 122 citations in OpenAlex.

  1. Article
  2. G protein GαThe Journal of biological chemistry · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Divergent Regulation of Mammary Lipogenesis byAnimals : an open access journal from MDPI · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. CaBiomolecules · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Signalling of Adrenoceptors: Canonical Pathways and New Paradigms.Handbook of experimental pharmacology · 2024
    Review
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yuh-Jiin I JongDepartment of Neuroscience, Washington University School of Medicine, St. Louis, MO, USA.
Steven K HarmonDepartment of Neuroscience, Washington University School of Medicine, St. Louis, MO, USA.
Karen L O'MalleyDepartment of Neuroscience, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-3064-3774
Washington University in St. Louis · US

Funding

SELECTIVE ACTIONS OF MGLU5 RECEPTOR NEGATIVE ALLOSTERIC MODULATORSR21MH109019 · NIMH · WASHINGTON UNIVERSITY · PI O'MALLEY, KAREN L · 2016 to 2017
$419k
LOCATION-DEPENDENT SIGNALING OF MGLU5 IN MODELS OF SYNAPTIC PLASTICITY USING CRISPR-TARGETED MICER21NS102783 · NINDS · WASHINGTON UNIVERSITY · PI O'MALLEY, KAREN L · 2017 to 2018
$419k
MECHANISMS UNDERLYING INTRACELLULAR MGLUR5 ROLE IN NOCICEPTIONR21NS081454 · NINDS · WASHINGTON UNIVERSITY · PI O'MALLEY, KAREN L · 2013 to 2014
$416k
NIMH NIH HHS R21 MH109019NINDS NIH HHS R21 NS081454NINDS NIH HHS R21 NS102783
6 · The paper itself

Abstract

Traditionally, signal transduction from GPCRs is thought to emanate from the cell surface where receptor interactions with external stimuli can be transformed into a broad range of cellular responses. However, emergent data show that numerous GPCRs are also associated with various intracellular membranes where they may couple to different signalling systems, display unique desensitization patterns and/or exhibit distinct patterns of subcellular distribution. Although many GPCRs can be activated at the cell surface and subsequently endocytosed and transported to a unique intracellular site, other intracellular GPCRs can be activated in situ either via de novo ligand synthesis, diffusion of permeable ligands or active transport of nonpermeable ligands. Current findings reinforce the notion that intracellular GPCRs play a dynamic role in various biological functions including learning and memory, contractility and angiogenesis. As new intracellular GPCR roles are defined, the need to selectively tailor agonists and/or antagonists to both intracellular and cell surface receptors may lead to the development of more effective therapeutic tools. LINKED ARTICLES: This article is part of a themed section on Molecular Pharmacology of GPCRs. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.21/issuetoc.

Indexed as

Signal TransductionAnimalsCellsHumansLigandsReceptors, G-Protein-CoupledLigandsReceptors, G-Protein-Coupled

Identifiers

PMID28872669
PMCPMC6177623
OpenAlexW2752607648

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.